E. Brochot

发表

Effect of Ribavirin on the Hepatitis C Virus (JFH-1) and its Correlation with Interferon Sensitivity

J. Dubuisson, G. Duverlie, C. François, 2007, Antiviral therapy.

Phylogenetic analysis of a circulating hepatitis C virus recombinant strain 1b/1a isolated in a French hospital centre.

G. Duverlie, C. François, S. Castelain, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Simeprevir for the treatment of hepatitis C virus infection

G. Duverlie, C. François, S. Castelain, 2014, Pharmacogenomics and personalized medicine.

Pre-Transplantation Assessment of BK Virus Serostatus: Significance, Current Methods, and Obstacles

A. Touzé, H. Akl, E. Brochot, 2019, Viruses.

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

G. Duverlie, C. François, S. Castelain, 2007, Virology Journal.

BK polyomavirus in the urine for follow-up of kidney transplant recipients.

G. Duverlie, C. François, S. Castelain, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review.

G. Duverlie, C. François, S. Castelain, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays

G. Duverlie, C. François, S. Castelain, 2020, Journal of Infection.

Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C Virus

J. Dubuisson, G. Duverlie, C. François, 2013, PloS one.

A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2

G. Even, C. Audebert, C. Olivier, 2022, PloS one.

A multiplex serological assay for the characterization of IgG immune response to SARS-CoV-2

G. Even, C. Audebert, C. Olivier, 2021, medRxiv.

Determination of IgG Response Profile in SARS-CoV-2 Patients Using a Multiplex Serological Assay

C. Audebert, R. Malbec, C. Olivier, 2021, Austin Journal of Public Health and Epidemiology.

Intercellular Transmission of Naked Viruses through Extracellular Vesicles: Focus on Polyomaviruses

G. Duverlie, F. Helle, E. Brochot, 2020, Viruses.

Patients treated with first‐generation HCV protease inhibitors exhibit high ribavirin concentrations

G. Duverlie, C. Solas, D. Capron, 2015, Journal of clinical pharmacology.

Which therapeutic option for hepatitis C virus genotype 1?

G. Duverlie, C. François, S. Castelain, 2015, Scandinavian journal of gastroenterology.

Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?

G. Duverlie, E. Brochot, S. Bodeau, 2015, Therapeutic drug monitoring.

Biological Risk Factors Predict Transfer to Intensive Care Units and Death in Covid-19 Patients

C. François, S. Castelain, L. Garçon, 2020 .

COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF

S. Castelain, O. Godefroy, E. Brochot, 2020, Journal of Neurology.

Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles

M. Koschinsky, G. Duverlie, C. François, 2017, Hepatology.

Ribavirin Monitoring in Chronic Hepatitis C Therapy: Anaemia versus Efficacy

G. Duverlie, C. François, S. Castelain, 2010, Antiviral therapy.

Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report.

G. Duverlie, C. François, S. Castelain, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

BK Polyomavirus bkv-miR-B1-5p: A Stable Micro-RNA to Monitor Active Viral Replication after Kidney Transplantation

C. François, S. Castelain, F. Helle, 2022, International journal of molecular sciences.

The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro.

G. Duverlie, C. François, S. Castelain, 2015, Antiviral research.

Roles of ITPA and IL28B genotypes in chronic Hepatitis C patients treated with peginterferon plus ribavirin in Tunisian population.

E. Brochot, V. Morel, L. Mouelhi, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A New Tool to Study Ribavirin-Induced Haemolysis

G. Duverlie, C. François, S. Castelain, 2012, Antiviral therapy.

The association between killer‐cell immunoglobulin‐like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation

S. Castelain, G. Choukroun, C. Presne, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

The Treatment Response of Chronically Hepatitis C Virus-Infected Patients Depends on Interferon Concentration but Not on Interferon Gene Expression in Peripheral Blood Mononuclear Cells

G. Duverlie, C. François, S. Castelain, 2011, Antimicrobial Agents and Chemotherapy.

Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics.

M. Fumery, E. Brochot, Clement Matias, 2020, Journal of Crohn's & colitis.

Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.

J. Dubuisson, H. Drobecq, C. Wychowski, 2018, Gastroenterology.

Virus Lifecycle and Identification of 3 Forms of the ORF 2 Capsid 2 Protein 3 4 Short title : 5

J. Dubuisson, H. Drobecq, J. Izopet, 2017 .

Comparison of Abbott Architect®, Siemens Immulite®, and Diasorin Liaison® for determination of Epstein-Barr virus serological diagnosis.

G. Duverlie, C. François, S. Castelain, 2018, Diagnostic microbiology and infectious disease.

Epidemiology and seasonality of acute respiratory infections in hospitalized children over four consecutive years (2012–2016)

G. Duverlie, C. François, S. Castelain, 2018, Journal of Clinical Virology.

Is there a role for SARS-CoV-2 antigen testing in the post-containment strategy?

E. Brochot, 2021, Journal of Clinical Virology Plus.

Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon‐alpha‐2b‐ribavirin combination therapy

G. Duverlie, C. François, S. Castelain, 2010, Journal of medical virology.

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

A. Fontanet, B. Hoen, S. Castelain, 2021, EBioMedicine.

Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein

J. Dubuisson, H. Drobecq, C. Wychowski, 2018 .

A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping

G. Duverlie, C. François, S. Castelain, 2017, Journal of Clinical Microbiology.

DHEA prevents ribavirin‐induced anemia via inhibition of glucose‐6‐phosphate dehydrogenase

G. Duverlie, L. Garçon, F. Helle, 2017, Antiviral research.

Biology of the BKPyV: An Update

G. Duverlie, C. François, S. Castelain, 2017, Viruses.

Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C

G. Duverlie, P. Mathurin, G. Riachi, 2013, Journal of medical virology.

Hemoglobin during ribavirin‐based HCV therapy is closely related to circulating levels of DHEA

G. Duverlie, M. Diouf, E. Nguyen-Khac, 2017, Journal of medical virology.

Hospital-wide SARS-CoV-2 antibody screening of 4840 staff members in a University Medical Center in France: a cross-sectional study

S. Castelain, M. Diouf, O. Ganry, 2022, BMJ Open.

Association between renin–angiotensin system inhibitors and COVID-19 complications

Y. Mahjoub, S. Liabeuf, O. Ganry, 2020, European heart journal. Cardiovascular pharmacotherapy.

Alginate Hydrogel Protects Encapsulated Hepatic HuH-7 Cells against Hepatitis C Virus and Other Viral Infections

G. Duverlie, C. François, S. Castelain, 2014, PloS one.

The standard treatment of HCV infection with pegylated interferon-a2a or -a2b and ribavirin is effective in <50%

G. Duverlie, C. François, S. Castelain, 2010 .

High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients

G. Duverlie, C. François, S. Castelain, 2017, Archives of Virology.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Equal efficacy between the two types of peginterferon on HCV: a matter of relapse?

G. Duverlie, E. Nguyen-Khac, E. Brochot, 2013, Antiviral research.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin

J. Pawlotsky, H. Fleury, G. Duverlie, 2015, Journal of Clinical Microbiology.

[Digestive tumors and pseudotumors that rarely get discussed. Case 1: colonic diverticulosis].

D. Chatelain, E. Brochot, C. Attencourt, 2013, Annales de pathologie.

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

J. Dubuisson, G. Duverlie, C. François, 2020, Frontiers in Microbiology.

Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in 1 SARS-CoV-2 inpatients and asymptomatic carriers 2

J. Dubuisson, G. Duverlie, C. François, 2020 .

Hepatitis C Virus Resistance to Carbohydrate-Binding Agents

J. Dubuisson, G. Duverlie, C. François, 2016, PloS one.

Genetic recombination of the hepatitis C virus: clinical implications

G. Duverlie, C. François, S. Castelain, 2011, Journal of viral hepatitis.

The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.

M. Stayoussef, E. Brochot, L. Mouelhi, 2015, Gene.

Comparative Evaluation of Three Nucleic Acid-Based Assays for BK Virus Quantification

G. Duverlie, C. François, S. Castelain, 2015, Journal of Clinical Microbiology.

TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection

W. Almawi, E. Brochot, L. Mouelhi, 2018, British journal of biomedical science.

Role of TLRs and IL‐6 in the outcome of chronic hepatitis C treatment in Tunisian population

W. Almawi, E. Brochot, L. Mouelhi, 2017, Cytokine.

DHEA and progesterone have a protective effect on ribavirin-induced hemolysis.

G. Duverlie, E. Nguyen-Khac, E. Brochot, 2014, Journal of hepatology.

Indoleamine 2,3-Dioxygenase Is Involved in Interferon Gamma’s Anti-BKPyV Activity in Renal Cells

G. Duverlie, C. François, S. Castelain, 2020, Viruses.

BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients

G. Duverlie, C. François, S. Castelain, 2021, Viruses.

No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation.

G. Duverlie, C. François, S. Castelain, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

BK Polyomavirus Hijacks Extracellular Vesicles for En Bloc Transmission

E. Blanchard, P. Roingeard, G. Duverlie, 2020, Journal of Virology.

Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities

C. François, S. Castelain, F. Bloch, 2021, The journal of nutrition, health & aging.

Strong Correlation between Liver and Serum Levels of Hepatitis C Virus Core Antigen and RNA in Chronically Infected Patients

G. Duverlie, C. François, S. Castelain, 2011, Journal of Clinical Microbiology.

Modeling of HBV and HCV hepatitis with hepatocyte-like cells.

G. Duverlie, A. Bengrine, E. Brochot, 2016, Frontiers in bioscience.

The End-of-Treatment Ribavirin Concentration Predicts Hepatitis C Virus Relapse

G. Duverlie, C. François, S. Castelain, 2013, Therapeutic drug monitoring.

Characteristics and outcomes of COVID‐19 in hospitalized patients with and without diabetes

H. Dupont, V. Goeb, J. Lalau, 2020, Diabetes/metabolism research and reviews.

Comparison of different serological assays for SARS-CoV-2 in real life

G. Duverlie, C. François, S. Castelain, 2020, Journal of Clinical Virology.

Claudin‐1, miR‐122 and apolipoprotein E transductions improve the permissivity of SNU‐182, SNU‐398 and SNU‐449 hepatoma cells to hepatitis C virus

J. Dubuisson, G. Duverlie, C. François, 2018, Journal of viral hepatitis.

BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy

C. Delaugerre, A. Amara, J. Molina, 2023, Transplant infectious disease : an official journal of the Transplantation Society.

The association between body mass index class and coronavirus disease 2019 outcomes

H. Dupont, V. Goeb, J. Lalau, 2020, International Journal of Obesity.

MICA and NKG2D variants as risk factors in spondyloarthritis: a case–control study

M. Fechtenbaum, J. Desoutter, N. Guillaume, 2018, Genes & Immunity.

Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

P. Marcellin, G. Duverlie, P. Trimoulet, 2019, Epidemiology and Infection.

Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers

J. Dubuisson, G. Duverlie, C. François, 2020, medRxiv.

The impact of pre-graft serology on the risk of BKPyV infection post-renal transplantation.

G. Duverlie, C. François, S. Castelain, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis

W. Almawi, E. Brochot, I. Sghaier, 2019, Reviews in medical virology.

Annexin-V positive extracellular vesicles level is increased in severe COVID-19 disease

M. Diouf, J. Maizel, M. Slama, 2023, Frontiers in Medicine.

Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status

G. Duverlie, C. François, S. Castelain, 2021, Vaccine.

Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France

A. Meola, A. Fontanet, S. Castelain, 2023, Open forum infectious diseases.

Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients.

G. Choukroun, Ophélie Fourdinier, H. Mazouz, 2023, Advances in therapy.

Thyrotropin Levels in Patients with Coronavirus Disease 2019: Assessment during Hospitalization and in the Medium Term after Discharge

J. Lalau, A. Al-Salameh, J. Maizel, 2022, Life.